“…Outcome measures included seizure freedom, 50% responder rate, reduction in seizure frequency, neuropsychological findings, congenital malformation, serious AEs, total AEs, single AEs and other outcomes (Figure 2A). Among the included RCTs, 12 compared LEV with placebo,52,55,56,58,60–63,65,66,68,78 9 compared LEV with CBZ,53,69,70,73,74,79–82 4 compared LEV with lamotrigine (LTG),57,64,71,81 3 compared LEV with phenobarbital (PB),64,75,85 3 compared LEV with VPA,70,74,82 2 compared LEV with oxcarbazepine (OXC),54,83 2 compared LEV with sulthiame,72,84 1 compared LEV with pregabalin,77 1 compared LEV with phenytoin59 and 1 compared LEV with topiramate 67. Outcome measures included seizure freedom, 50% responder rate, reduction in seizure frequency, QoL, serious AEs, total AEs, single AEs and other outcomes (Figure 2B).…”